RESECTABLE NSCLC
Clinical trials for RESECTABLE NSCLC explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE NSCLC trials appear
Sign up with your email to follow new studies for RESECTABLE NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against tough lung cancer before surgery
Disease control Recruiting nowThis study tests a new treatment approach for people with a specific type of lung cancer (KRAS G12C mutation) that can be removed by surgery. About 30 participants will receive a targeted pill (fulzerasib) for 6 weeks, followed by a short break, then 3 cycles of immunotherapy (si…
Matched conditions: RESECTABLE NSCLC
Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo before lung surgery shows promise in early trial
Disease control Recruiting nowThis phase II trial is testing whether giving the immunotherapy drug tislelizumab along with radiation therapy before surgery can help eliminate more cancer in people with resectable non-small cell lung cancer (NSCLC). About 20 participants will receive the combination, then have…
Matched conditions: RESECTABLE NSCLC
Phase: PHASE2 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC